ReviewFrontiers in cellular and infection microbiology2017
Prevention and Control Strategies to Counter Dengue Virus Infection.
Review in Frontiers in cellular and infection microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
45 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A Systematic Review of Mathematical Models of Dengue Transmission and Vector Control: 2010-2020.Viruses · 2023Pooled it
- Immunogenicity, Safety, and Efficacy of a Tetravalent Dengue Vaccine in Children and Adolescents: An Analysis by Age Group.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025Trial
- Biological control strategy with Poecilia reticulata for the reduction of Aedes spp. and Culex sp. in urban stormwater drains: Experience at Universidad del Valle, Cali, ColombiaBiomedica : revista del Instituto Nacional de Salud · 2026Article
- Vector control strategies for preventing dengue transmission.The Cochrane database of systematic reviews · 2026Article
- Article
- Assessing dengue knowledge, attitudes and preventive practices in France and Italy: A cross-sectional study using participatory surveillance cohorts.PLOS global public health · 2026Article
- A national report on 2024 dengue fever outbreak in Iran: has the game changed?BMC infectious diseases · 2025Article
- Knowledge, attitude and practice towards dengue fever prevention and treatment among health care workers in Somalia: a cross-sectional study.BMC health services research · 2025Article
- Mosquito and global dengue cases in a warming world.BMJ global health · 2025Article
- Pathogenesis and clinical management of arboviral diseases.World journal of virology · 2025Review
- Understanding Dengue Underreporting: An Analysis of the Impacts for the World, Latin America and Brazil.TheScientificWorldJournal · 2025Review
- Review of selected mosquito-borne diseases: arboviruses (dengue, chikungunya, Zika, West Nile, Japanese encephalitis, yellow fever) and parasitic diseases (malaria, lymphatic Filariasis).Frontiers in public health · 2025Review
- Unlocking Success: Determining Predictors of High-Performance among COMBI Community Health Volunteers in Kuala Lumpur and Putrajaya.Iranian journal of public health · 2024Article
- Seroprevalence and hematological profile of dengue among healthy inhabitants of Mayo Kebbi province: South of Tchad.Journal of family medicine and primary care · 2024Article
- Estimating the force of infection of four dengue serotypes from serological studies in two regions of Vietnam.PLoS neglected tropical diseases · 2024Article
- Reduced protein-coding transcript diversity in severe dengue emphasises the role of alternative splicing.Life science alliance · 2024Article
- Deciphering dengue: novel RNA barcoding segments for enhanced serotype-specific identification and global surveillance of dengue viruses.Frontiers in microbiology · 2024Article
- Scaling artificial light at night and disease vector interactions into socio-ecological systems: a conceptual appraisal.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023Review
- Review
- Multi-epitope vaccine candidate design for dengue virus.Bioinformation · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dengue is currently the highest and rapidly spreading vector-borne viral disease, which can lead to mortality in its severe form. The globally endemic dengue poses as a public health and economic challenge that has been attempted to suppress though application of various prevention and control techniques. Therefore, broad spectrum techniques, that are efficient, cost-effective, and environmentally sustainable, are proposed and practiced in dengue-endemic regions. The development of vaccines and immunotherapies have introduced a new dimension for effective dengue control and prevention. Thus, the present study focuses on the preventive and control strategies that are currently employed to counter dengue. While traditional control strategies bring temporary sustainability alone, implementation of novel biotechnological interventions, such as sterile insect technique, paratransgenesis, and production of genetically modified vectors, has improved the efficacy of the traditional strategies. Although a large-scale vector control strategy can be limited, innovative vaccine candidates have provided evidence for promising dengue prevention measures. The use of tetravalent dengue vaccine (CYD-TDV) has been the most effective so far in treating dengue infections. Nonetheless, challenges and limitation hinder the progress of developing integrated intervention methods and vaccines; while the improvement in the latest techniques and vaccine formulation continues, one can hope for a future without the threat of dengue virus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.